Invivyd, Inc.
IVVD· Nasdaq· Biological Products, (No Diagnostic Substances)
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- -109.1%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- –
We record prices for the companies we cover; IVVD is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 172.2M
- Revenue
- $53.4M
- Free cash flow
- -$58.3M
- Owner earnings
- -$69.9M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- –
- Operating
- -104.0%
- Net
- -98.2%
- Free cash flow
- -109.1%
- Owner earnings
- -130.9%
- Stock pay
- 21.8%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- -21.7%
- ROE, 5 yr avg
- -98.7%
Growth (CAGR)
- Revenue, 3 yr
- –
- Revenue, 5 yr
- –
- Revenue, 4 yr
- –
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- –
- Diluted EPS, 4 yr
- –
- Free cash flow, 3 yr
- –
- Free cash flow, 5 yr
- –
- Free cash flow, 4 yr
- –
Financial health · FY2025
- Cash and investments
- $226.7M
- Total debt
- –
- Net cash
- –
- Debt/Equity
- –
- Debt/FCF
- –
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- –
Financials: ten years from the 10-Ks
Revenue
$53.4M
FY2025
FY2021FY2025
Margins
Operating-104.0%Net-98.2%
FY2025
FY2021FY2025
Free cash flow and owner earnings
Free cash flow-$58.3MOwner earnings-$69.9M
FY2025
FY2021FY2025
Diluted shares
172.2M
+304.1% over 4 years, net dilution
FY2021FY2025
Every figure, year by year
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| The business | |||||
| Revenue | – | – | $0 | $25.4M | $53.4M |
| Revenue growth | – | – | – | – | 110.5% |
| Gross margin | – | – | – | – | – |
| Operating margin | – | – | – | -696.8% | -104.0% |
| Net income | -$226.8M | -$241.3M | -$198.6M | -$169.9M | -$52.5M |
| Net margin | – | – | – | -669.4% | -98.2% |
| Diluted EPS | $-5.32 | $-2.23 | $-1.81 | $-1.43 | $-0.30 |
| Return on invested capital? | – | – | – | – | – |
| Cash | |||||
| Operating cash flow | -$184.7M | -$220.0M | -$173.2M | -$170.5M | -$58.1M |
| Capital expenditure | $84.0K | $1.7M | $615.0K | $140.0K | $155.0K |
| Free cash flow | -$184.8M | -$221.7M | -$173.8M | -$170.6M | -$58.3M |
| Stock-based compensation | $17.8M | $21.6M | $18.7M | $19.8M | $11.6M |
| Owner earnings? | -$202.6M | -$243.3M | -$192.5M | -$190.4M | -$69.9M |
| Free cash flow per share | $-4.34 | $-2.05 | $-1.59 | $-1.44 | $-0.34 |
| Capital allocation | |||||
| Dividends paid | – | – | – | – | – |
| Share repurchases | $0 | $4.0K | $1.0K | $0 | – |
| Diluted shares | 42.6M | 108.3M | 109.5M | 118.6M | 172.2M |
| Share count change? | – | 154.0% | 1.2% | 8.2% | 45.3% |
| Balance sheet | |||||
| Cash and equivalents | $542.2M | $92.1M | $200.6M | $69.3M | $226.7M |
| Short-term investments | – | – | – | – | – |
| Total debt | – | – | – | – | – |
| Net debt | – | – | – | – | – |
| Shareholders' equity | $558.0M | $356.0M | $177.5M | $67.5M | $241.5M |
Latest filings
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-13 | 8-K | Earnings release |
| 2026-05-14 | 10-Q | Quarterly report |
| 2026-05-14 | 8-K | Earnings release |
| 2026-04-06 | DEF 14A | Proxy statement |
| 2026-03-05 | 10-K | Annual report |
| 2026-03-05 | 8-K | Earnings release |
| 2026-01-08 | 8-K | Earnings release |
| 2025-11-06 | 10-Q | Quarterly report |
| 2025-11-06 | 8-K | Earnings release |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
